The novel minimally invasive mechano-chemical technique of the saphenous vein ablation. Our center experience: results of 24 months follow-up
Phlebogriffe – a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study
A NEW DEVICE FOR MINIMALLY INVASIVE MECHANO-CHEMICAL METHOD OF SAPHENOUS VEIN ABLATION. REPORT OF 12 MONTHS OF FOLLOW UP
APPLICATION OF ENDOVENOUS MECHANOCHEMICAL ABLATION (MOCA) WITH FLEBOGRIFTM TO TREAT VARICOSE VEINS OF THE LOWER EXTREMITIES: A SINGLE CENTER EXPERIENCE OVER 3 MONTHS OF OBSERVATION
TRATAMIENTO DE LAS LESIONES EN BIFURCACIÓN MEDIANTE EL STENT DEDICADO BIOSS: RESULTADOS CLÍNICOS Y ANGIOGRÁFICOS AL AÑO
Resultados a largo plazo del tratamiento con stent farmacoactivo con polimero biodegradable vs polimero bioestable
Assessment of effectiveness of endovascular treatment of common and external iliac artery stenosis/occlusion using self-expanding Jaguar SM stents
Experimental Evaluation of Pharmacokinetic Profile and Biological Effect of a Novel Paclitaxel Microcrystalline Balloon Coating in the Iliofemoral Territory of Swine.
Differences in vessel healing following delivery of everolimus or paclitaxel: a comparative experimental study using identical stent and biodegradable polymer platforms.
OCT evaluati on of the ti me course of vessel healing following implantati on of new generati on biodegradable polymer-coated and sirolimus-eluti ng cobalt-chromium coronary stent system (ALEX OCT Study).
LONG TERM RESULTS OF PERCUTANEOUS CORONARY TREATMENT: DEDICATED STENT VS REGULAR DES TREATMENT.
First-in-man study of dedicated bifurcation sirolimus eluting stent – interim analysis of BiOSS LIM Registry.
Regular drug eluting stent versus dedicated bifurcation paclitaxel-eluting stent in coronary bifurcation treatment (POLBOS study) – interim analysis.